Leandro Vetcher
Fondatore presso Clade Therapeutics, Inc.
Posizioni attive di Leandro Vetcher
Società | Posizione | Inizio | Fine |
---|---|---|---|
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Direttore operativo | - | - |
Fondatore | - | - |
Storia della carriera di Leandro Vetcher
Precedenti posizioni note di Leandro Vetcher
Società | Posizione | Inizio | Fine |
---|---|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Keclon SA
Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Direttore/Membro del Consiglio | 01/12/2011 | - |
Fondatore | 01/12/2011 | - | |
Public Communications Contact | 01/12/2011 | - | |
Green Pacific Biologicals, Inc.
Green Pacific Biologicals, Inc. Chemicals: SpecialtyProcess Industries Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 14/07/2008 | - |
Amministratore Delegato | 14/07/2008 | - | |
Fondatore | 14/07/2008 | - |
Formazione di Leandro Vetcher
The Trustees of Columbia University in The City of New York | Graduate Degree |
National University of Rosario | Undergraduate Degree |
Massachusetts Institute of Technology | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Argentina | 3 |
Posizioni
Founder | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Green Pacific Biologicals, Inc.
Green Pacific Biologicals, Inc. Chemicals: SpecialtyProcess Industries Green Pacific Biologicals, Inc. develops algae biofuel technologies and produces algae biofuel. The firm also produces algae biofuel. The company was founded by Ian Burbulis, Carlos Gustavo Pesce, Wallace Marshall, Richard Yu and Leandro Vetcher on July 14, 2008 and is headquartered in San Francisco, CA. | Process Industries |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Keclon SA
Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | Health Technology |
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Leandro Vetcher
- Esperienza